Holen Sie sich die Stockscreener-App
24.25
0.03%
0.0322
Schlusskurs vom Vortag:
$24.28
Offen:
$24.57
24-Stunden-Volumen:
1.63M
Relative Volume:
0.47
Marktkapitalisierung:
$4.48B
Einnahmen:
$637.78M
Nettoeinkommen (Verlust:
$239.40M
KGV:
20.36
EPS:
1.1909
Netto-Cashflow:
$307.21M
1W Leistung:
-4.16%
1M Leistung:
-2.93%
6M Leistung:
-65.81%
1J Leistung:
-60.06%
1-Tages-Spanne:
$24.00
$24.74
1-Wochen-Bereich:
$24.00
$25.71
52-Wochen-Spanne:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.26 | 4.48B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
178.19 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.02 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.25 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
77.75 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Franklin Resources Inc. Increases Stake in Doximity, Inc. $DOCS - MarketBeat
First Trust Advisors LP Lowers Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Insider Sells $63,622.16 in Stock - MarketBeat
Insider Selling: Doximity (NASDAQ:DOCS) Insider Sells $58,833.03 in Stock - MarketBeat
Sitaram Siddharth sells Doximity shares worth $58,833 - Investing.com UK
Sitaram Siddharth sells Doximity shares worth $58,833 By Investing.com - Investing.com India
Doximity interim PFO Sitaram sells $63,622 in shares - Investing.com South Africa
Doximity interim PFO Sitaram sells $63,622 in shares By Investing.com - Investing.com Australia
Capital World Investors Boosts Stake in Doximity - National Today
Capital World Investors Increases Position in Doximity, Inc. $DOCS - MarketBeat
American Century Companies Boosts Doximity Stake by 60% - National Today
American Century Companies Inc. Has $16.30 Million Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Stock is Down 75% From Its Highs. Do Analysts See Recovery? - TIKR.com
Doximity (NASDAQ:DOCS) Receives "Outperform" Rating from Royal Bank Of Canada - MarketBeat
What Analysts Are Saying About Doximity Stock - Benzinga
Rhenman & Partners Asset Management AB Increases Stake in Doximity, Inc. - National Today
Rhenman & Partners Asset Management AB Increases Position in Doximity, Inc. $DOCS - MarketBeat
Blair William & Co. IL Acquires 345,390 Shares of Doximity, Inc. $DOCS - MarketBeat
What Wall Street predicts for Doximity Inc. stock price2026 Key Lessons & Verified Chart Pattern Signals - Naître et grandir
(DOCS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Victory Capital Management Inc. Acquires 921,533 Shares of Doximity, Inc. $DOCS - MarketBeat
Assessing Doximity (DOCS) Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform - Sahm
Doximity (NASDAQ:DOCS) Director Sells $52,000.00 in Stock - MarketBeat
Is Doximity Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Breakouts Watch: Is Doximity Inc stock a hidden gemWall Street Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Hims and Hers Expands Its Technology Driven Consumer Health Platform - The Globe and Mail
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Doximity Analysts Set $44.50 Average Price Target - National Today
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance
DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan
Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? - Yahoo Finance
Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - simplywall.st
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Intech Investment Management Trims Doximity Holdings - National Today
Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews
Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm
Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo
Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity’s $31 Million Investor Settlement Clears Initial Hurdle - Bloomberg Law News
Doximity Stock Hits Day Low of $23.58 Amid Price Pressure - Markets Mojo
Doximity, Inc. Stock Plummets to New 52-Week Low of $23.58 - Markets Mojo
Doximity Stock Analysts Adjust Ratings and Targets - National Today
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Doximity (DOCS) Price Target Decreased by 31.04% to 44.25 - Nasdaq
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.41%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):